Results 41 to 50 of about 59,312 (337)

Gastroesophageal reflux disease: risk factors, current possibilities of diagnosis and treatment optimisation

Медицинский совет, 2022
Gastroesophageal reflux disease (GERD) is one of the most common causes of health care seeking at the primary care level in many countries. At an epidemiological level, GERD has been shown to be associated with a number of risk factors: obesity, tobacco ...
I. V. Maev, D. N. Andreev, M. A. Ovsepyan, E. V. Barkalova   +3 more
doaj   +1 more source

Not All Children with Cystic Fibrosis Have Abnormal Esophageal Neutralization during Chemical Clearance of Acid Reflux. [PDF]

, 2017
PurposeAcid neutralization during chemical clearance is significantly prolonged in children with cystic fibrosis, compared to symptomatic children without cystic fibrosis.
Di Lorenzo, Carlo, Hayes, Don, Jadcherla, Sudarshan R, Kaul, Ajay, Kopp, Benjamin T, Machado, Rodrigo Strehl, Moore-Clingenpeel, Melissa, Mousa, Hayat, Nemastil, Christopher J, Woodley, Frederick W   +9 more
core   +3 more sources

Sustained efficacy following resolution of frequent heartburn with an over-the-counter regimen of esomeprazole 20 mg or placebo for 14 days: two randomized trials

BMC Gastroenterology, 2018
Background A two-week course of therapy with an over-the-counter proton-pump inhibitor (PPI) is recommended for frequent heartburn. Limited research has been conducted on the sustained efficacy of short-term PPI therapy after treatment cessation ...
David A. Peura, Anne Le Moigne, Heather Wassel, Charles Pollack   +3 more
doaj   +1 more source

The effect of adding duloxetine to lansoprazole on symptom and quality of life improvement in patients with gastroesophageal reflux diseases: A randomized double-blind clinical trial

Journal of Research in Medical Sciences, 2021
Background: Gastroesophageal reflux disease (GERD) is a common upper gastrointestinal disorder with a negative impact on the quality of life. This study was aimed to assess the effect of adding duloxetine to lansoprazole on the symptom and quality of ...
Marjan Mokhtare, Arezoo Chaharmahali, Mansour Bahardoust, Atefeh Ghanbari, Arash Sarveazad, Roozbeh Naghshin, Farbod Abbaskhanidavanloo   +6 more
doaj   +1 more source

Diagnosis and outcome of oesophageal Crohn's disease [PDF]

, 2019
BACKGROUND AND AIMS: Crohn's disease (CD) can involve any part of the gastrointestinal tract. We aimed to characterize clinical, endoscopic, histologic features and treatment outcomes of CD patients with oesophageal involvement.
Beaton, D, Chaparro, M, Ellul, P, Katsanos, K, Oliveira, AM, et al., Rodrigues, R, Savarino, E, Sladek, M, Teich, N, van der Woude, J, Vavricka, R, Wei, J   +11 more
core   +1 more source

Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction [PDF]

, 2013
Background: This phase I/II-trial assessed the dose-limiting toxicities (DLT) and maximum tolerated dose (MTD) of neoadjuvant radiochemotherapy (RCT) with docetaxel and oxaliplatin in patients with locally advanced adenocarcinoma of the oesophagogastric ...
Arnold, Dirk, Brenner, Baruch, Galle, Peter R., Gockel, Ines, Klautke, Gunther, Lang, Hauke, Möhler, Markus, Roessler, Hans-Peter, Rödel, Claus, Schimanski, Carl Christoph, Schmidberger, Heinz, Thomaidis, Thomas, Trarbach, Tanja   +12 more
core   +1 more source

Anxiety Associated With Increased Risk for Emergency Department Recidivism in Patients With Low-Risk Chest Pain [PDF]

, 2018
Anxiety contributes to the chest pain symptom complex in 30% to 40% of patients with low-risk chest pain seen in the emergency department (ED). The validated Hospital Anxiety Depression Scale-Anxiety subscale (HADS-A) has been used as an anxiety ...
Fry, Colin, Jimenez, Guadalupe, Kline, Jeffrey A., Koene, Rachael, Musey, Paul I., Jr., Patel, Roma   +5 more
core   +1 more source

Treatment of Gastrointestinal Disorders—Plants and Potential Mechanisms of Action of Their Constituents

Molecules, 2022
The worldwide prevalence of gastrointestinal diseases is about 40%, with standard pharmacotherapy being long-lasting and economically challenging. Of the dozens of diseases listed by the Rome IV Foundation criteria, for five of them (heartburn, dyspepsia,
Szilvia Czigle, Silvia Bittner Fialová, Jaroslav Tóth, Pavel Mučaji, Milan Nagy, on behalf of the OEMONOM   +5 more
doaj   +1 more source

Safety and Efficacy of Almagate and Simethicone Combination in Symptomatic Management of GERD: Post-marketing Observational TRIALMA Study [PDF]

Journal of Clinical and Diagnostic Research, 2020
Introduction: Gastroesophageal Reflux Disease (GERD) is one of the most common conditions worldwide with a significant impact on quality of life. Almagate and simethicone act as antacid and antiflatulent agents, respectively and aid in relief of GERD ...
Tariq A Patel, Monil Patel, K Rajagopalan, Rakesh Patel, Aftab S Shaikh, Satyajit Ray, Sunit Arora, Jagjit Singh   +7 more
doaj   +1 more source

Toward a Lockean Unification of Formal and Traditional Epistemology [PDF]

, 2022
Can there be knowledge and rational belief in the absence of a rational degree of confidence? Yes, and cases of "mistuned knowledge" demonstrate this. In this paper we leverage this normative possibility in support of advancing our understanding of the ...
Lee, Matthew Brandon, Silva Jr, Paul
core